Form 4: Edward T. Mathers Acquires Stock Options in Senti Biosciences, Inc.
SEC Form 4 Filing
Director Edward T. Mathers acquired stock options in Senti Biosciences, Inc. on March 7, 2025.
Summary
- On March 7, 2025, Edward T. Mathers, a director of Senti Biosciences, Inc. (SNTI), acquired stock options to purchase 43,900 shares of common stock at an exercise price of $3.52.
- The options vest on the first anniversary of the grant date, contingent upon Mathers' continued service.
- Following the transaction, Mathers directly owns 43,900 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. It is common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The granting of stock options to a director aligns their interests with those of the shareholders, potentially incentivizing them to work towards increasing the company's value.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of stock option transaction. |
| 03/06/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.